ARTL

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Artelo Biosciences Inc

NASDAQ | ARTL

1.72

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$3.35M

Market Cap

-

P/E Ratio

-18.71

EPS

$28.60

52 Week High

$1.52

52 Week Low

HEALTHCARE

Sector

ARTL Chart

Recent Chart
Price Action

ARTL Technicals

Tags:

ARTL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$10M
Selling General And Administrative $4.1M
Research And Development $6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$9.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.8M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$9.8M

Revenue & Profitability

Earnings Performance

ARTL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.7M
Total Current Assets $2.6M
Cash And Cash Equivalents At Carrying Value $2.3M
Cash And Short Term Investments $2.3M
Inventory -
Current Net Receivables -
Total Non Current Assets $2.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2M
Intangible Assets Excluding Goodwill $2M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $219K
Other Non Current Assets -
Total Liabilities $1.8M
Total Current Liabilities $1.8M
Current Accounts Payable $1.7M
Deferred Revenue -
Current Debt -
Short Term Debt $35K
Total Non Current Liabilities $69K
Capital Lease Obligations $104K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $104K
Other Current Liabilities $58K
Other Non Current Liabilities -
Total Shareholder Equity $2.9M
Treasury Stock -
Retained Earnings -$50M
Common Stock $3K
Common Stock Shares Outstanding $3.2M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$8.4M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $7.8M
Cashflow From Financing $112K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.8M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$10M
Selling General And Administrative $4.1M
Research And Development $6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$9.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.8M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$9.8M

ARTL News

ARTL Profile

Artelo Biosciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Artelo Biosciences Inc. (ARTL), headquartered in La Jolla, California, is a clinical-stage biopharmaceutical firm focused on developing innovative therapies that utilize the endocannabinoid system to tackle a range of medical challenges. The company aims to enhance cannabinoid efficacy through its diverse pipeline, which primarily targets oncology, pain management, and appetite stimulation. With a commitment to scientific rigor and compliance with regulatory standards, Artelo is poised to address significant unmet needs in the cannabinoid therapeutics sector, presenting a compelling opportunity for institutional investors seeking growth in the biopharmaceutical space.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
BITF
+12.58%
$3.49
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
INTC
+2.73%
$36.81
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CLSK
+13.01%
$15.20
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
BMNR
+3.76%
$32.93
BIYA
+5.51%
$0.26
SRM
+53.27%
$10.30
BAC
+0.97%
$52.99
INHD
+2.21%
$0.23
ONMD
+31.69%
$1.87
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
CHR
-1.86%
$0.04
CIFR
+8.04%
$20.69
SNAP
+0.14%
$7.62
TSLA
+0.55%
$428.96
BMNU
+9.61%
$8.24
PCG
+1.78%
$16.01
PLUG
+2.09%
$2.02
ADTX
+19.42%
$3.75
AFMD
-34.94%
$0.18
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
F
+0.65%
$13.27
KWM
+17.00%
$0.77
DEFT
+11.51%
$1.55
WULF
+7.27%
$15.92
NIO
+0.36%
$5.48
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
GOOGL
-0.60%
$318.02
BTG
+3.13%
$4.61
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
IBRX
+9.81%
$2.33
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
GRAB
+2.63%
$5.46
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
AG
+12.76%
$15.23
CAN
+12.59%
$1.03
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
LEN
+0.15%
$131.28
SHOT
-74.37%
$0.39
CRCA
+22.28%
$4.50
ZAPP
-46.30%
$0.15
AMD
+1.01%
$216.41
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
CRCG
+21.08%
$2.84
PFE
+0.19%
$25.75
AMZN
+1.39%
$232.35
NVO
+1.38%
$49.38
WBD
+0.94%
$24.10
RIG
+1.97%
$4.38
GOOG
-0.73%
$317.92
KO
+0.37%
$72.88
ABVE
+11.49%
$2.93
TMC
+14.32%
$6.66
SNDK
+4.28%
$224.25
AGNC
-0.66%
$10.49
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
NVTS
+6.83%
$8.91
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
BITF
+12.58%
$3.49
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
INTC
+2.73%
$36.81
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CLSK
+13.01%
$15.20
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
BMNR
+3.76%
$32.93
BIYA
+5.51%
$0.26
SRM
+53.27%
$10.30
BAC
+0.97%
$52.99
INHD
+2.21%
$0.23
ONMD
+31.69%
$1.87
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
CHR
-1.86%
$0.04
CIFR
+8.04%
$20.69
SNAP
+0.14%
$7.62
TSLA
+0.55%
$428.96
BMNU
+9.61%
$8.24
PCG
+1.78%
$16.01
PLUG
+2.09%
$2.02
ADTX
+19.42%
$3.75
AFMD
-34.94%
$0.18
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
F
+0.65%
$13.27
KWM
+17.00%
$0.77
DEFT
+11.51%
$1.55
WULF
+7.27%
$15.92
NIO
+0.36%
$5.48
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
GOOGL
-0.60%
$318.02
BTG
+3.13%
$4.61
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
IBRX
+9.81%
$2.33
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
GRAB
+2.63%
$5.46
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
AG
+12.76%
$15.23
CAN
+12.59%
$1.03
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
LEN
+0.15%
$131.28
SHOT
-74.37%
$0.39
CRCA
+22.28%
$4.50
ZAPP
-46.30%
$0.15
AMD
+1.01%
$216.41
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
CRCG
+21.08%
$2.84
PFE
+0.19%
$25.75
AMZN
+1.39%
$232.35
NVO
+1.38%
$49.38
WBD
+0.94%
$24.10
RIG
+1.97%
$4.38
GOOG
-0.73%
$317.92
KO
+0.37%
$72.88
ABVE
+11.49%
$2.93
TMC
+14.32%
$6.66
SNDK
+4.28%
$224.25
AGNC
-0.66%
$10.49
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
NVTS
+6.83%
$8.91
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.